Partners HealthCare and Illumina, Inc. (NASDAQ:ILMN) today announced the GeneInsight-Illumina Founding Network Members, including the ARUP Laboratories, Mount Sinai Genetic Testing Laboratory, New York Genome Center (NYGC), Partners HealthCare, and Illumina. The members represent a diverse and distinguished group of laboratories within leading academic institutions and commercial organizations who are interested in leveraging clinical-grade genomics interpretation and reporting. The members are committed to exploring and sharing knowledge, including variant level content and interpretations, through the formation of inter-laboratory collaborations and “knowledge rings.” The network will be opened widely later in 2013 to other institutions willing to share clinical genomic data.
“Today’s announcement reinforces our commitment to establishing a community-based approach to addressing some of the most challenging issues related to clinical next-generation sequencing,” said Heidi Rehm, PhD, Chief Laboratory Director, Partners’ Laboratory for Molecular Medicine. “We’re excited to bring together such a talented and diverse group of leading institutions who share a common vision and are passionate about the opportunities for collaboration to advance the field of clinical genetics.”
Elaine Lyon, PhD, Medical Director, ARUP Laboratories echoes this sentiment and expressed her enthusiasm for a community approach to curating variant knowledge saying, “As a user of the GeneInsight application, I look forward to participating in a network of leading genetic testing laboratories and academic institutions to curate genetic variants. This collaborative effort can greatly contribute to improving patient care.”
The founding members are serving as initial pilot sites for the deployment and implementation of a combined offering that integrates the functionality of Illumina’s MiSeq® sequencing system and Partners GeneInsight Suite®, an IT platform that streamlines the analysis, interpretation, and reporting of complex genetic test results. As pilot sites, the members have a unique opportunity to represent the community of clinical lab professionals, geneticists and genetic counselors to improve upon the combined GeneInsight-Illumina offering and to prepare it for general release. They also will be instrumental in developing a resource that has the potential to add to the effectiveness of genetic testing.